Medical Academy named after I. Mechnikov, St. Petersburg

Saint Petersburg 195067

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 1, Myocardial Infarction

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed